Modern molecular profiling recontextualizes the NRG/RTOG 0539 trial and reveals hidden high-risk and radiotherapy-resistant meningiomas Article

Yefet, Leeor S, Landry, Alexander P, Rogers, C Leland et al. (2026). Modern molecular profiling recontextualizes the NRG/RTOG 0539 trial and reveals hidden high-risk and radiotherapy-resistant meningiomas . NEURO-ONCOLOGY, 28(7), 1727-1740. 10.1093/neuonc/noag081

cited authors

  • Yefet, Leeor S; Landry, Alexander P; Rogers, C Leland; Wang, Justin Z; Liu, Jeff; Patil, Vikas; Gui, Chloe; Ajisebutu, Andrew; Ellenbogen, Yosef; Wei, Qingxia; Singh, Olivia; Mansouri, Sheila; Szot, Christopher; Jordan, Richard C; Barani, Igor J; Straza, Michael W; Shu, Hui-Kuo G; Pointer, Kelli B; Hunter, Grant; Panet-Raymond, Valerie; Shi, Wenyin; Perlow, Haley K; Kavanagh, Brian D; Gunter, Tyler; Robinson, Clifford; Pugh, Stephanie L; Dicker, Adam P; Mehta, Minesh P; Chakravarti, Arnab; Nassiri, Farshad; Aldape, Kenneth; Zadeh, Gelareh

authors

publication date

  • July 1, 2026

published in

keywords

  • CLASSIFICATION
  • Clinical Neurology
  • DNA methylation
  • Life Sciences & Biomedicine
  • MULTICENTER
  • Neurosciences & Neurology
  • Oncology
  • Science & Technology
  • histopathology
  • meningioma
  • molecular classification
  • radiotherapy

Digital Object Identifier (DOI)

publisher

  • OXFORD UNIV PRESS INC

start page

  • 1727

end page

  • 1740

volume

  • 28

issue

  • 7